Page last updated: 2024-08-21

alpha-aminopyridine and Dementias, Transmissible

alpha-aminopyridine has been researched along with Dementias, Transmissible in 7 studies

Research

Authors	Studies
Carvalho, DM; Filho, SPL; Júnior, JAC; Júnior, RMA; Lima, PTMBQ; Magalhães, JGM; Melo, HMA; Miranda, LHL; Oliveira, AFPH; Souza, GMF	1
Nieznanska, H; Nieznanski, K; Zajkowski, T	1
Geschwind, MD	1
Sakaguchi, S	1
Müller, WE; Schröder, HC	1
Keogh, GF; Knight, RS; Rydzewska, LH; Stewart, LA	1
Böhm, M; Meesters, E; Meinhardt, A; Müller, WE; Pergande, G; Perovic, S	1

4 review(s) available for alpha-aminopyridine and Dementias, Transmissible

Article	Year
Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far? Arquivos de neuro-psiquiatria, 2022, Volume: 80, Issue:8 Topics: Aminopyridines; Creutzfeldt-Jakob Syndrome; Doxycycline; Humans; Pentosan Sulfuric Polyester; Prion Diseases; Quinacrine	2022
[Systematic review of the therapeutics for prion diseases]. Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:8 Topics: Aminopyridines; Animals; Antibodies, Monoclonal; Blood-Brain Barrier; Brain; Cattle; Clinical Trials as Topic; Drug Discovery; Gene Silencing; Humans; Pentosan Sulfuric Polyester; Polyelectrolytes; Polymers; Prion Diseases; Protein Isoforms; PrPC Proteins; PrPSc Proteins; Quinacrine; Species Specificity	2009
Neuroprotective effect of flupirtine in prion disease. Drugs of today (Barcelona, Spain : 1998), 2002, Volume: 38, Issue:1 Topics: Aminopyridines; Animals; Calcium; Genes, bcl-2; Glutathione; Humans; Neuroprotective Agents; Prion Diseases	2002
Systematic review of therapeutic interventions in human prion disease. Neurology, 2008, Apr-08, Volume: 70, Issue:15 Topics: Aminopyridines; Analgesics; Clinical Trials as Topic; Creutzfeldt-Jakob Syndrome; Disease Progression; Drug Evaluation, Preclinical; Humans; Neuropharmacology; Prion Diseases; Survival Rate; Treatment Failure	2008

3 other study(ies) available for alpha-aminopyridine and Dementias, Transmissible

Article	Year
Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein. Biochimica et biophysica acta, 2015, Volume: 1853, Issue:10 Pt A Topics: Aminopyridines; Animals; Antimanic Agents; Cells, Cultured; Glycogen Synthase Kinase 3; Lithium Chloride; Microtubule-Associated Proteins; Microtubules; Necrosis; Neurites; Peptide Fragments; Prion Diseases; Prions; Pyrimidines; Rats; Rats, Wistar	2015
Clinical trials for prion disease: difficult challenges, but hope for the future. The Lancet. Neurology, 2009, Volume: 8, Issue:4 Topics: Aminopyridines; Clinical Trials as Topic; Humans; Prion Diseases; Quinacrine; Randomized Controlled Trials as Topic	2009
Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases. Mechanisms of ageing and development, 1998, Mar-16, Volume: 101, Issue:1-2 Topics: Aging; Alzheimer Disease; Amino Acid Sequence; Aminopyridines; Amyloid beta-Peptides; Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Glutamates; Molecular Sequence Data; Neurons; Neuroprotective Agents; Peptide Fragments; Prion Diseases; Prions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors	1998